1.
Schizophr Res
; 202: 310-315, 2018 12.
Article
in English
| MEDLINE
| ID: mdl-29935882
Subject(s)
Affective Symptoms/physiopathology , Apathy/physiology , Psychotic Disorders/physiopathology , Social Behavior , Adolescent , Adult , Anhedonia/physiology , Cross-Sectional Studies , Factor Analysis, Statistical , Female , Hong Kong , Humans , Male , Prospective Studies , Risk , Volition , Young Adult
2.
Hong Kong Med J
; 15(5): 394-6, 2009 Oct.
Article
in English
| MEDLINE
| ID: mdl-19801701
ABSTRACT
We present a case of a 17-year-old man with first-episode schizophrenia who developed olanzapine-induced hepatitis, cholestasis, and splenomegaly, all of which were reversed after ceasing olanzapine. Clinicians prescribing olanzapine should be aware of this possible hepatotoxicity. Patient education, vigilance from clinicians, and careful clinical examination can help detect this complication early.